HYDERABAD: Pharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Unit V facility ...
Aditya Birla SL Pure Value Fund (G) 145.05 25,46,492 2.26 Aditya Birla SL Pure Value Fund (IDCW) 145.05 25,46,492 2.26 Aditya Birla SL Pure Value Fund - Direct (G ...
Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion Hydrochloride extended-release tablets USP (SR), expanding its presence in the US ...
Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 13,392.08 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback